These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 24535378

  • 1. Overweight is associated with improved survival and outcomes in patients with atrial fibrillation.
    Wang J, Yang YM, Zhu J, Zhang H, Shao XH, Tian L, Huang B, Yu LT, Gao X, Wang M.
    Clin Res Cardiol; 2014 Jul; 103(7):533-42. PubMed ID: 24535378
    [Abstract] [Full Text] [Related]

  • 2. Impact of Body Mass Index on the Prognosis of Japanese Patients With Non-Valvular Atrial Fibrillation.
    Inoue H, Kodani E, Atarashi H, Okumura K, Yamashita T, Origasa H, J-RHYTHM Registry Investigators.
    Am J Cardiol; 2016 Jul 15; 118(2):215-21. PubMed ID: 27255662
    [Abstract] [Full Text] [Related]

  • 3. Body mass index and all-cause mortality in patients with atrial fibrillation: insights from the China atrial fibrillation registry study.
    Wang L, Du X, Dong JZ, Liu WN, Zhou YC, Li SN, Guo XY, Jiang CX, Yu RH, Sang CH, Tang RB, Long DY, Liu N, Bai R, Macle L, Ma CS.
    Clin Res Cardiol; 2019 Dec 15; 108(12):1371-1380. PubMed ID: 30953181
    [Abstract] [Full Text] [Related]

  • 4. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L, Li N, Wang G, Su K, Li F, Yang L, Ren J, Chang S, Chen S, Wu S, He J, Dai M.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar 15; 35(3):231-6. PubMed ID: 24831616
    [Abstract] [Full Text] [Related]

  • 5. BMI differences among in-hospital management and outcomes in patients with atrial fibrillation: findings from the Care for Cardiovascular Disease project in China.
    Deng F, Zhang Y, Zhao Q, Deng Y, Gao S, Zhang L, Dong M, Yuan Z, Lei X, CCC-AF investigators.
    BMC Cardiovasc Disord; 2020 Jun 05; 20(1):270. PubMed ID: 32503432
    [Abstract] [Full Text] [Related]

  • 6. Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.
    Badheka AO, Rathod A, Kizilbash MA, Garg N, Mohamad T, Afonso L, Jacob S.
    Am J Med; 2010 Jul 05; 123(7):646-51. PubMed ID: 20609687
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The impact of body weight and diabetes on new-onset atrial fibrillation: a nationwide population based study.
    Kim YG, Han KD, Choi JI, Boo KY, Kim DY, Oh SK, Lee KN, Shim J, Kim JS, Kim YH.
    Cardiovasc Diabetol; 2019 Oct 01; 18(1):128. PubMed ID: 31575379
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Association between obesity and short- and medium-term mortality in critically ill patients with atrial fibrillation: a retrospective cohort study.
    Yang D, Ye S, Zhang K, Huang Z, Zhang L.
    BMC Cardiovasc Disord; 2023 Mar 23; 23(1):150. PubMed ID: 36959537
    [Abstract] [Full Text] [Related]

  • 11. Gender-specific association between body mass index and all-cause mortality in patients with atrial fibrillation.
    Lyu SQ, Yang YM, Zhu J, Wang J, Wu S, Zhang H, Shao XH, Ren JM.
    Clin Cardiol; 2020 Jul 23; 43(7):706-714. PubMed ID: 32352584
    [Abstract] [Full Text] [Related]

  • 12. Body mass index and adverse events in patients with incident atrial fibrillation.
    Overvad TF, Rasmussen LH, Skjøth F, Overvad K, Lip GY, Larsen TB.
    Am J Med; 2013 Jul 23; 126(7):640.e9-17. PubMed ID: 23601271
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased risk of major bleeding in underweight patients with atrial fibrillation who were prescribed non-vitamin K antagonist oral anticoagulants.
    Park CS, Choi EK, Kim HM, Lee SR, Cha MJ, Oh S.
    Heart Rhythm; 2017 Apr 23; 14(4):501-507. PubMed ID: 28042092
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of body mass index on real-world outcomes of rivaroxaban treatment in Japanese patients with non-valvular atrial fibrillation.
    Murakawa Y, Ikeda T, Ogawa S, Kitazono T, Nakagawara J, Minematsu K, Miyamoto S, Hayashi Y, Kidani Y, Okayama Y, Sunaya T, Sato S, Yamanaka S.
    Heart Vessels; 2020 Aug 23; 35(8):1125-1134. PubMed ID: 32253531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial.
    Boriani G, Ruff CT, Kuder JF, Shi M, Lanz HJ, Rutman H, Mercuri MF, Antman EM, Braunwald E, Giugliano RP.
    Eur Heart J; 2019 May 14; 40(19):1541-1550. PubMed ID: 30624719
    [Abstract] [Full Text] [Related]

  • 20. Do acute hospitalised patients in Australia have a different body mass index to the general Australian population: a point prevalence study?
    Dennis DM, Carter V, Trevenen M, Tyler J, Perrella L, Lori E, Cooper I.
    Aust Health Rev; 2018 Apr 14; 42(2):121-129. PubMed ID: 28225703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.